{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:12:42Z","timestamp":1788581562657,"version":"build-2803163510"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.2169\/internalmedicine.6562-25","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T22:08:09Z","timestamp":1769897289000},"page":"2310-2316","source":"Crossref","is-referenced-by-count":0,"title":["Fungal Sensitization and the Manifestation of Asthmatic Features in Chronic Obstructive Pulmonary Disease"],"prefix":"10.2169","volume":"65","author":[{"given":"Yuta","family":"Kono","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Aoshiba","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reimi","family":"Mizushima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kogami","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Ishiwari","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Togashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet (London) 399: 2227-2242, 2022.","DOI":"10.1016\/S0140-6736(22)00470-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hosseini M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S. Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis. Respir Res 20: 229, 2019.","DOI":"10.1186\/s12931-019-1198-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hikichi M, Hashimoto S, Gon Y. Asthma and COPD overlap pathophysiology of ACO. Allergol Int 67: 179-186, 2018.","DOI":"10.1016\/j.alit.2018.01.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mekov E, Nu\u00f1ez A, Sin DD, et al. Update on asthma-COPD overlap (ACO): a narrative review. Int J Chron Obstruct Pulmon Dis 16: 1783-1799, 2021.","DOI":"10.2147\/COPD.S312560"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J 44: 1697-1700, 2014.","DOI":"10.1183\/09031936.00162414"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fattahi F, ten Hacken NH, L\u00f6fdahl CG, et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respir Res 14: 10, 2013.","DOI":"10.1186\/1465-9921-14-10"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jamieson DB, Matsui EC, Belli A, et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188: 187-192, 2013.","DOI":"10.1164\/rccm.201211-2103OC"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Simon-Nobbe B, Denk U, P\u00f6ll V, Rid R, Breitenbach M. The spectrum of fungal allergy. Int Arch Allergy Immunol 145: 58-86, 2008.","DOI":"10.1159\/000107578"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tiew PY, Ko FWS, Pang SL, et al. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. Eur Respir J 56: 2020.","DOI":"10.1183\/13993003.00418-2020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tiew PY, Narayana JK, Quek MSL, et al. Sensitisation to recombinant <i>Aspergillus fumigatus<\/i> allergens and clinical outcomes in COPD. Eur Respir J 61: 2200507, 2023.","DOI":"10.1183\/13993003.00507-2022"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miravitlles M, Alvarez-Gutierrez FJ, Calle M, et al. Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines. Eur Respir J 49: 1700068, 2017.","DOI":"10.1183\/13993003.00068-2017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Miyashita N, Matsushima T, Oka M; Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med 45: 419-428, 2006.","DOI":"10.2169\/internalmedicine.45.1691"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med 4: 390-398, 2016.","DOI":"10.1016\/S2213-2600(16)00100-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Calverley PMA, Tetzlaff K, Vogelmeier C, et al. Eosinophilia, frequent exacerbations, and steroid response in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 196: 1219-1221, 2017.","DOI":"10.1164\/rccm.201612-2525LE"},{"key":"15","unstructured":"15. The Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management and Prevention of COPD: 2024 Report. 2024."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bo\u017cek A, Rogala B. IgE-dependent sensitization in patients with COPD. Ann Agric Environ Med 25: 417-420, 2018.","DOI":"10.26444\/aaem\/83413"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Weiss ST. Atopy as a risk factor for chronic obstructive pulmonary disease: epidemiological evidence. Am J Respir Crit Care Med 162: S134-136, 2000.","DOI":"10.1164\/ajrccm.162.supplement_2.ras-16"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sherrill DL, Lebowitz MD, Halonen M, Barbee RA, Burrows B. Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med 152: 98-102, 1995.","DOI":"10.1164\/ajrccm.152.1.7599870"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Aghapour M, Raee P, Moghaddam SJ, Hiemstra PS, Heijink IH. Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure. Am J Respir Cell Mol Biol 58: 157-169, 2018.","DOI":"10.1165\/rcmb.2017-0200TR"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hellings PW, Steelant B. Epithelial barriers in allergy and asthma. J Allergy Clin Immunol 145: 1499-1509, 2020.","DOI":"10.1016\/j.jaci.2020.04.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kortekaas Krohn I, Seys SF, Lund G, et al. Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation. Allergy 75: 1155-1164, 2020.","DOI":"10.1111\/all.14132"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hersh CP, Zacharia S, Prakash Arivu Chelvan R, et al. Immunoglobulin E as a biomarker for the overlap of atopic asthma and chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis 7: 1-12, 2020.","DOI":"10.15326\/jcopdf.7.1.2019.0138"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Toyota H, Sugimoto N, Kobayashi K, et al. Comprehensive analysis of allergen-specific IgE in COPD: mite-specific IgE specifically related to the diagnosis of asthma-COPD overlap. Allergy Asthma Clin Immunol 17: 13, 2021.","DOI":"10.1186\/s13223-021-00514-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Agarwal R, Hazarika B, Gupta D, Aggarwal AN, Chakrabarti A, Jindal SK. <i>Aspergillus<\/i> hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol 48: 988-994, 2010.","DOI":"10.3109\/13693781003743148"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bafadhel M, McKenna S, Agbetile J, et al. <i>Aspergillus fumigatus<\/i> during stable state and exacerbations of COPD. Eur Respir J 43: 64-71, 2014.","DOI":"10.1183\/09031936.00162912"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Huerta A, Soler N, Esperatti M, et al. <i>Importance of Aspergillus spp.<\/i> isolation in acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. Respir Res 15: 17, 2014.","DOI":"10.1186\/1465-9921-15-17"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Everaerts S, Lagrou K, Dubbeldam A, et al. Sensitization to <i>Aspergillus fumigatus<\/i> as a risk factor for bronchiectasis in COPD. Int J Chron Obstruct Pulmon Dis 12: 2629-2638, 2017.","DOI":"10.2147\/COPD.S141695"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Snelgrove RJ, Gregory LG, Peir\u00f3 T, et al. Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol 134: 583-592 e6, 2014.","DOI":"10.1016\/j.jaci.2014.02.002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hiraishi Y, Yamaguchi S, Yoshizaki T, et al. IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammation. Sci Rep 8: 18052, 2018.","DOI":"10.1038\/s41598-018-36440-x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kobayashi T, Iijima K, Radhakrishnan S, et al. Asthma-related environmental fungus, <i>Alternaria<\/i>, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol 182: 2502-2510, 2009.","DOI":"10.4049\/jimmunol.0802773"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/17\/65_6562-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:31:17Z","timestamp":1788579077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/17\/65_6562-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":30,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6562-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"6562-25"}}